about
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyondPartners in Public Health: Public Health Collaborations With Schools of Pharmacy, 2015.Role of glucagon-like peptide 1 receptor agonists in management of obesity.Considerations and controversies in managing chronic kidney disease: An update.A Chronic Disease State Simulation in an Ambulatory Care Elective CourseJazzin' Healthy: Interdisciplinary Health Outreach Events Focused on Disease Prevention and Health Promotion.Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor AgonistAdjunct Antihyperglycemic Agents in Overweight and Obese Adults With Type 1 DiabetesDiabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care and Education Specialists, the Academy of Nutrition and Dietetics, the American
P50
Q26799389-8593AB38-1F04-4E8E-A33F-7B4628E365B1Q30148743-945013D3-BAFC-41FB-AD20-FC7EE8C5F246Q30248510-0F54A99C-2CA6-47B2-937D-AB8F71AE6484Q39331265-E694B9A9-BEB7-4C42-8201-EF574F79A95BQ41871553-4EF130DD-946D-47FB-85F0-3A1F34DB64AAQ47832334-4188E06B-5576-4E44-9CD7-FCCF5867409EQ89145783-2C45DA4E-4763-4EDE-B431-180A4833FF5AQ93382757-4E6A8A21-3B80-4706-BE83-0DF175A845CDQ96229896-36C8F4E4-50AE-426A-9C19-B369E2850618
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-5743-9458
@en
name
Diana Isaacs
@ast
Diana Isaacs
@en
Diana Isaacs
@es
Diana Isaacs
@nl
type
label
Diana Isaacs
@ast
Diana Isaacs
@en
Diana Isaacs
@es
Diana Isaacs
@nl
prefLabel
Diana Isaacs
@ast
Diana Isaacs
@en
Diana Isaacs
@es
Diana Isaacs
@nl
P106
P1153
53163904500
P21
P31
P496
0000-0002-5743-9458